Company Monitoring Page for Amylin

latest headlines for company on cafepharma

FDA to review Amylin, Lilly diabetes drug
Reuters
Fri, 05/7/10 - 08:35 am
Tags:
FDA, Eli Lilly, Amylin, Byetta, diabetes
Make Money From 2020's Blockbuster Drugs
Motley Fool
Tue, 04/27/10 - 09:33 pm
Tags:
Abbott Laboratories, Amgen, Bristol-Myers Squibb, Sanofi, Novartis, Pfizer, AstraZeneca, Amylin, Merck, Novo Nordisk
Amylin Pharmaceuticals' 1st-quarter loss narrows on lower sales force, research costs
Yahoo/AP
Mon, 04/19/10 - 11:30 am
Tags:
Amylin, earnings
What’s Ahead for Biotech Earnings
Minyanville
Sat, 04/17/10 - 12:11 pm
Tags:
biotech, earnings, Amylin, Gilead Sciences, Biogen Idec, Amgen, Genzyme
Biotech Earnings: Large-Cap Preview
TheStreet.com
Wed, 04/14/10 - 10:46 am
Tags:
earnings, Amylin, Biogen Idec, Gilead Sciences, Vanda, Genzyme, Amgen, Alexion, Celgene, Allos
NVO's Victoza More Effective
Yahoo/Zacks.com
Wed, 03/31/10 - 10:05 am
Tags:
Novo Nordisk, Victoza, diabetes, Amylin, GSK, Eli Lilly
FDA to Review VIVUS Drug
Yahoo/Zacks.com
Mon, 03/29/10 - 11:23 am
Tags:
FDA, obesity, Vivus, Orexigen, Arena Pharmaceuticals, Qnexa, Amylin
FDA Says "No Way!" Market Says "Yeah, Baby!"(Byetta)
Motley Fool
Mon, 03/15/10 - 04:20 pm
Tags:
FDA, Amylin, Alkermes, Byetta, diabetes, Eli Lilly
Amylin, Alkermes Gain as FDA Doesn’t Need More Byetta Data
Bloomberg
Mon, 03/15/10 - 11:49 am
Tags:
Amylin, Alkermes, FDA, diabetes, Byetta
Industry News Bytes: Delcath, Amylin and Access Pharma
Seeking Alpha
Mon, 03/15/10 - 11:40 am
Tags:
Delcath, Access Pharmaceuticals, Amylin, Eli Lilly, Alkermes, Eisai
Amylin shares fall ahead of diabetes drug decision
Yahoo/AP
Thu, 03/11/10 - 06:17 pm
Tags:
diabetes, Amylin, Byetta, exanitide, FDA
10 Biotech Stocks On the Line
TheStreet.com
Thu, 03/11/10 - 08:57 am
Tags:
Medivation, InterMune, Allos, Affymax, Amylin, Alkermes, Cell Therapeutics, Delcath, Dendreon, GenVec, MannKind, Somaxon, Vertex Pharmaceuticals
For Biotech in 2010, It's Déjà Vu All Over Again
Seeking Alpha
Mon, 03/8/10 - 10:23 am
Tags:
Alkermes, Amylin, MannKind, Cell Therapeutics, Dendreon, Isis Pharmaceuticals, Amag Pharmaceuticals, XenoPort, Novelos Therapeutics, Adventrx, Delcath
Amylin Pharmaceuticals May Have a Great Shot
Barron's
Fri, 02/26/10 - 08:31 am
Tags:
Amylin, exanitide
Amylin’s Other Drug to Watch
Minyanville
Wed, 02/24/10 - 10:10 am
Tags:
Amylin, Takeda, obesity
Healthcare a Focus for Big Moves by Icahn
Yahoo/Indie Research
Fri, 02/19/10 - 10:51 am
Tags:
Carl Icahn, Biogen Idec, Amylin, Genzyme, Forest Labs, Exelixis
Roche’s Diabetes Drug Meets Goals in Five Studies
Bloomberg
Thu, 02/11/10 - 08:36 am
Tags:
Roche, diabetes, clinical trials, Lantus, Byetta, Januvia, taspoglutide, Eli Lilly, Merck, Amylin, Sanofi
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 10:58 am
Tags:
FDA, Cadence Pharmaceuticals, Acorda Therapeutics, Auxilium, Gilead Sciences, Shire, Amylin, Cell Therapeutics, Dendreon, InterMune, Amgen, Human Genome, NicOx, Vivus, Arena Pharmaceuticals, Orexigen
Alkermes Retains Neutral Rec
Yahoo/Zacks.com
Tue, 02/9/10 - 09:34 am
Tags:
Alkermes, Amylin, JNJ
Novo Nordisk Has High Hopes for Diabetes Blockbuster
Seeking Alpha
Wed, 02/3/10 - 09:50 am
Tags:
Novo Nordisk, Amylin, diabetes, Victoza

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.